Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
HOME > COMMENTARY
COMMENTARY
-
FPMAJ Chair’s Call for Blanket Drug Price Hike: Bold Pitch or Wild Throw?
September 30, 2025
-
MHLW Grows Jittery over Supply Risks amid Rising Foreign Investments
September 8, 2025
-
Pharmacies Reel from Pricey Drug Waste, Sparking Calls for Packaging Overhaul and Price Penalties
August 27, 2025
-
As Japan’s Contract Drug Rep Ratio Rises, Expectations Grow for Specialist Talent and Flexible Workforce
August 5, 2025
-
Pharmaceutical Policy at a Crossroad amid Political Upheaval in Japan
July 28, 2025
-
Taking on Solid Tumors - 9: ADCs Surge Ahead as TCEs Strive for a Foothold
July 18, 2025
-
FY2024 Sees Divergence in I/O Drug Sales, Keytruda Thrives while Rivals Face Pricing Headwinds
July 4, 2025
-
Honebuto 2025 Approved - The Real Battle for Pharma Lies Ahead
June 23, 2025
-
Next Wave of ALS Drugs Emerging as Novartis, Nipro Enter Development Fray
May 27, 2025
-
Impact of US Drug Policy: President Trump Shaking the World of Pharma
May 19, 2025
-
New Grad Hires for Sales Reps Up after 5 Years of Decrease: FY2025 Survey
May 8, 2025
-
How Will Japan Deal with Expected Cost Spike with Japan-Made Antibiotic APIs?
April 1, 2025
-
Fair or Unfair? PMP Return Applied for First Time in Off-Year Revision
March 24, 2025
-
Evolving GLP-1 Drugs: Could Double and Triple Agonists Achieve Blockbuster Status?
March 4, 2025
-
New Govt Fund for Innovative Drugs: Twists, Turns, and Hope
February 10, 2025
-
Companies Welcome Generic Drug Fund, but Fret Pricing and Regulations
February 5, 2025
-
Japan’s Redefinition of “High-Priority” Vaccines Likely to Speed Up Discussions on NIP Access
January 27, 2025
-
Japan Expects to Approve/List 43 Novel Drugs in 2025 Including Ultra-Expensive Gene Therapies
January 9, 2025
-
Where Do Japan Drug Makers Stand? A Comparison with Other Industries and Mega Pharma Peers
December 24, 2024
-
Battle over Off-Year Price Revision Now Heading for Political Settlement
December 13, 2024
